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Abstract: The HIV-1, HIV-2 and SIV Nef protein are known to modulate the expression of several cell surface receptors 
and molecules to escape the immune system, to alter T cell activation, to enhance viral replication, infectivity and 
transmission and overall to ensure the optimal environment for infection outcome. Consistent and continuous efforts have 
been made over the years to characterize the modulation of expression of each of these molecules, in the hope that a better 
understanding of these processes essential for HIV infection and/or pathogenesis will eventually highlight new therapeutic 
targets. In this article we provide an extensive review of the knowledge gained so far on this important and evolving topic. 
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INTRODUCTION 
 Receptor down-modulation is a strategy broadly used by 
many viruses to escape the immune system and establish the 
best environment for their replication and spread [1-5]. HIV-
1 seems to have evolved to master the art of receptor 
modulation to perfection. Infection with the virus causes the 
differential expression of several receptors from the surface 
of T cells and antigen presenting cells such as dendritic cells 
and macrophages. These receptors are CD4 (reviewed in [6] 
and [7]), CD3 [8], CXCR4 [9], CCR5 [10], CCR3 [11], CD1 
[12], MHC-I [13], CD8 [14], CD80 and CD86 [15], CD28 
[16] and MHC-II [17] and DC-SIGN [18], and in general 
their down-regulation (or up-regulation, in the case of DC-
SIGN) leads to enhanced virus release, reduced 
superinfection and disruption of immunological responses, 
thus creating the perfect environment for viral replication. 
 The small genome of HIV-1, encoding only three 
structural genes and six regulatory/accessory proteins [19], 
necessitates optimal use of the limited coding capacity to 
perform all viral functions. It is therefore not surprising that 
multifunctional proteins arose, such as Nef that determines 
most of the receptor down-regulation phenomena occurring 
during HIV-1 infection. This protein is considered important 
for HIV-1 infectivity and pathogenicity. The structure, 
reviewed by Geyer, Fackler and Peterlin [20] in 2001, and 
some functions of Nef have already been clarified in part, 
while for other functions only hypothetical mechanistic 
models have been proposed. In the massive amount of litera-
ture that has been produced on Nef over the years, contra-
dictory results on the receptor modulation mechanisms have 
been published, probably in part due to the use of different 
experimental systems, including less relevant cell lines. An 
example of this contradiction can be found in two very 
recent works [21, 22]. The use of relevant cell lines, and 
especially of primary cells, is key to gain relevant consistent 
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evidence and more insights in the exact ways of action and 
functions of the Nef protein. Here we review the biological 
relevance and the importance of the different receptor 
expression modulation processes provoked by Nef. Our hope 
is that the knowledge gained until now will help to better 
direct the efforts in the study of these mechanisms in the 
future. 
 The down-modulation of surface receptors and molecules 
is considered one of the most important and conserved 
functions of the HIV-1 Nef protein, with relevance for 
pathogenicity. The down-regulation of each receptor leads to 
specific biological consequences and all together they 
contribute to create a synergy necessary for the efficient 
replication and infection of HIV. It is believed that the 
down-modulation of MHC-I, CD8, CD4, CD1a, CD28, 
MHC-II and CXCR4 are fundamental to ensure an efficient 
immune evasion [23]. The down-regulation of CD4, one of 
the hallmarks of HIV-1 infection, leads to the efficient 
assembly of viral particles, to the disruption of CD4-based 
immune responses and contributes to avoid superinfection 
[7]. Finally, the down-regulation of CD80 and CD86 is 
believed to interfere with naïve T cell activation [15]. All 
together, these phenomena lead to a perfect environment for 
optimal fitness and propagation of the virus and will be 
discussed in detail in the following paragraphs. 
HIV-1 NEF DOWN-MODULATES CELL SURFACE 
RECEPTORS TO HIJACK AND ESCAPE THE 
IMMUNE SYSTEM 
 The Nef protein, produced during the early stages of 
infection, plays a crucial role in creating the perfect 
environment for viral replication and reduces the ability of 
the infected cells to induce an immune response, leaving 
them isolated from any possible immune reaction that could 
kill it or interfere with the virus production [6]. Here, we 
discuss the contribution of the down-modulation of each of 
these molecules to the effective viral escape from the 
immune system. 
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CD4 
 CD4 is the co-receptor of the T Cell Receptor (TCR) of 
CD4 positive T cells and also the main receptor for HIV-1: 
binding with the viral envelope protein Env determines a series 
of conformational changes that result in the eventual fusion of 
the viral and cellular membranes and the entry of the virus into 
the host cell [24]. In the early stages of infection, Nef acts in 
order to eliminate the CD4 receptor from the surface. It is now 
clear that Nef binds to CD4 and the clathrin adaptor AP-2 and 
uses this interaction to recruit clathrin molecules to the 
membrane and therefore accelerates the endocytosis of CD4 
through clathrin-coated vescicles [14, 25]. It has been shown 
that Nef interaction with -COP might be important to direct the 
endocytosed receptors to the endosomal pathways that lead to 
degradation [26], a finding that has been validated recently also 
for CD8 and CD28 down-regulation [21]. In 2009 Bonifacino et 
al. showed, in HeLa cells stably expressing the CD4 receptor 
and in JM T cells, that Nef has also the ability of targeting CD4 
to the Multivesicular Body Pathway (MVP) for lysosomal 
degradation with a separated system from surface down-
modulation that involves the Endosomal Sorting Complex 
Required for Transport (ESCRT) [27]. This finding has revived 
a question ongoing for many years: are there other proteins, 
apart from AP-2 and -COP, involved in the down-modulation 
of CD4? Which is the exact pathway? It is clear that these 
questions need to be answered if we want to really understand 
this important function of the Nef protein and its effects on HIV 
infection. Moreover, based on research from others and our own 
unpublished results, we believe that validation of all these 
findings should be done in primary T cells, given the variability 
and the difference in protein trafficking between different cell 
lines. In addition to Nef, also two other viral proteins act to 
ensure an efficient down-modulation of the receptor: Env 
(gp160), which retains newly synthesized CD4 molecules in the 
endoplasmic reticulum and Vpu, which links the gp160-bound 
CD4 molecules to the SCF ubiquitin ligase for degradation [28]. 
The CD4 co-receptor is necessary for T cell activation upon 
recognition of the MHC-II:antigen complex and is required for 
productive signaling that leads to the immune response to 
pathogen infection [29]. Kitchen et al. demonstrated in mice 
[30] and humans [31] that the expression of the CD4 molecule 
on cytotoxic lymphocytes has a functional role in antiviral 
response in vivo: CD4 on highly activated CD8+ lymphocytes 
serves as a chemotactic receptor for IL-16, which attracts the 
lymphocytes to the site of inflammation, and the binding of 
CD4 to MHC-II is also able to up-regulate the expression of 
IFN- and FasL. HIV might use the CD4 receptor expressed on 
cytotoxic T lymphocytes to enter this type of cells and 
immediately down-regulate it from the cell surface upon entry, 
dysregulating FasL induction, IFN- production and IL-16 
binding, thus reducing the efficiency of the cytotoxic response 
against antigen. 
 CD4 down-modulation does not only have consequences 
on the immune response, but as the HIV receptor, viral 
infectivity and replication are also affected, as discussed in 
the following paragraphs of this review. 
Major Histocompatibility Complex, Class I (MHCI) 
 To escape from lysis of infected cells, HIV must evade 
the action of cytotoxic T lymphocytes (CTLs) which, in 
normal conditions, function to destroy virally infected cells. 
CTLs can recognize infected targets via the TCR that 
together with CD8, recognizes the MHC-I molecule 
presenting the pathogen antigen on the surface of the 
infected cells. Nef is known to down-modulate MHC-I from 
the cell surface in order to successfully avoid recognition of 
CTLs and thus contribute to the escape of the virus from the 
immune system [13]. After the discovery of this function of 
Nef, many studies have tried to characterize the mechanism 
behind it. A study of Roeth et al. reported that Nef first binds 
to the cytoplasmic tail of MHC-I early in the secretory 
compartment, in contrast to CD4 down-regulation which 
happens when CD4 is already present on the surface [32]. 
Subsequently, the Nef-MHC-I complex recruits AP-1 using a 
binding site that is created when the Nef-MHC-I complex is 
formed and stabilized thanks to the acidic and polyproline 
domains of Nef [32, 33]. The formation of this complex 
diverts MHC-I trafficking in a way that the protein is 
directed to lysosomes for degradation instead of being 
expressed on the cell surface. In a following study by the 
same group, the mechanism is further characterized by the 
validation of the role of -COP in the trafficking of MHC-I 
to the degradative compartment: knock-down of -COP 
hampers both CD4 and MHC-I degradation. This suggests a 
model in which CD4 and MHC-I are first escorted to 
endosomal compartments via the interaction with AP-2 and 
AP-1 respectively, and then led to degradation by a common 
pathway involving the interaction with -COP [26]. A recent 
study by the same group validated these findings and added 
further insights by comparing the down-modulation of the 
MHC-I molecule with the down-modulation of other cell 
surface receptors and molecules by Nef. Interestingly, the 
study reports that the interaction between Nef and AP-1 
needed to mediate the down-regulation of CD28 and CD8 
requires the tyrosine binding pocket in the μ subunit of AP-1, 
different from the Nef-AP1 interaction that permits down-
modulation of MHC-I, which is dependent on the dileucine 
motif within Nef. Moreover, the role of -COP in the 
degradation of internalized CD4, CD8 and MHC-I is further 
validated [21]. It can be speculated that Nef acts 
predominantly in the elimination of nascent MHC-I 
molecules, and not on the ones already expressed on the cell 
surface, because only the newly synthesized molecules 
would harbor viral antigens, while the ones already present 
on the cell-surface prior to infection wouldn’t trigger an anti-
HIV CTLs response and rather inhibit NK activation. 
Major Histocompatibility Complex, Class II (MHCII) 
 In order to impair the host immune response to viral 
infections, antigen presentation in the context of MHC-II is 
another target for viral immune subversion. MHC-II is 
expressed on antigen-presenting cells (APCs) such as 
macrophages and dendritic cells and binds to the T cell and 
CD4 receptors present on T-helper lymphocytes to play a 
fundamental role in the immune response. Loss of functional 
MHC-II molecules on APCs surface hampers antigen 
presentation and therefore leads to an absent or defective T-
helper lymphocyte-mediated immune response. 
 Studies in HeLa cells stably transfected with CIITA (that 
induces the expression of genes necessary for MHC-II 
presentation, i.e. Ii, HLA-DM, HLA-DR) determined that 
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not only the levels of mature MHC-II on the cell surface are 
reduced in the presence of Nef, but also that the expression 
of an immature MHC-II molecule, containing the invariant 
chain Ii, is increased and this function appears to be specific 
for the Nef protein, since it is not observed during infection 
with Nef-deleted viruses. Mechanistic studies revealed that 
Nef impairs the transport of the internalized invariant chain 
Ii to the lysosomes, where it is normally degraded. This 
effect was shown to be sensitive to the phosphoinositide 3-
kinase (PI3K) inhibitor LY294002, suggesting that Nef could 
stimulate PI3K activation, possibly leading to recycling of 
the Ii chain to the cellular surface [34-37]. Taken together 
these data confirm the hypothesis that Nef can hamper 
antigen presentation by avoiding the maturation of the MHC-
II complexes. In contrast, the down-regulation of mature 
MHC-II from the surface is determined by a completely 
different pathway and requires other molecular effectors. 
The first insights in the molecular pathway involved, came 
from Chaudry et al., who used both murine and human 
monocytic-derived cell lines but also human peripheral 
blood mononuclear cells [17]. They showed that despite the 
MHC-II down-regulation from the cellular surface the total 
amount of MHC-II remains constant. This must be due to an 
intracellular accumulation and thus demonstrates that Nef 
retains the internalized MHC-II molecules in the endocytic 
vesicles, hampering their recycling and expression on the 
cell surface. The internalized MHC-II molecules co-localize 
with markers of the endosomes and lysosomes and the 
process seems to be dependent on cholesterol presence in the 
plasma membrane, Rab5 and PI3K but independent of 
clathrin, dynamin and other cytoskeleton proteins involved 
in the Nef mediated down-regulation of other surface 
molecules. Taken together, these studies show that Nef 
induces the reduction of surface mature MHC-II expression 
by inducing its re-localization to the lysosomes for 
degradation. 
 A study of Schindler et al. validated the fact that the 
MHC-II down-regulation/Ii-chain up-regulation function of 
Nef is conserved among different strains (HIV-1 Na7, HIV-1 
NL4.3, SIVmac239 and HIV-2 Ben) [36]. The conservation 
of this function, not only among alleles of HIV-1 Nef but 
also in SIV and HIV-2, suggests that it is a very important 
function for the virus. This study confirmed the previous 
results and added some important observations: these effects 
on MHC-II expression are observed with primary isolates 
from HIV-1 infected patients that show progression to AIDS, 
while in Long Term Non Progressors (LNTPs) these 
functions seems to be absent. This suggests an important role 
of mature MHC-II down-regulation for the progression of 
the disease. The study of Schindler et al. also determined the 
Nef motives involved in the process: the acidic domain 
(EEEE) appears to be necessary for MHC-II down-regulation 
but dispensable for Ii chain up-regulation while the acidic 
residues of the C-terminal proximal loop appear to be important 
for the up-regulation of the Ii chain and dispensable for MHC-II 
down-regulation. The dileucine motif, also important in Nef-
mediated CD4 down-modulation, seems important for the up-
regulation of the Ii chain while the residues Pro72 and Pro75 of 
the PxxP motif were important for mature MHC-II down-
modulation. So far, all these functions have been detected in cell 
lines only: the group of Schindler et al. performed preliminary 
experiments in PBMCs but could not validate the findings 
obtained in cell lines [36]. Once again, most mechanisms 
were researched in cell lines but only some of these aspects 
were confirmed in part in primary cells [37, 38]: given the 
importance of the MHC-II molecule in the immune response 
and the conservation of the MHC-II down-modulation 
function among a wide range Nef alleles, it is of great 
importance to define the mechanism in primary monocytes 
and dendritic cells, in order to have a clearer and more 
relevant view on the process. 
CD8 
 The transmembrane glycoprotein CD8, is a co-receptor 
of the TCR and can be found on intestinal T cells, CD8+ T 
cells, thymic T cell precursors and Natural Killer cells as an 
-homodimer and on thymocytes and peripheral T cells as 
an -heterodimer [39, 40]. The latter was reported to be 
strongly down-modulated by HIV-1, HIV-2 and SIVmac239 
Nef in T cell precursors and CD4+T cell lines [14, 21]. 
Results indicate that HIV-1 Nef induces the rapid 
internalization of the  chain of the receptor by clathrin-
mediated endocytosis, recruiting the AP-2 adaptor complex 
to the cell surface in order to facilitate the receptor 
internalization. This mechanism reveals a similarity between 
the CD8 and the CD4 down-modulation processes [14]. The 
effect on the covalently linked  chain appears much more 
modest compared to the  chain, suggesting CD8 down-
modulation is mediated mainly by its effect on the  chain. 
Recently, Leonard et al. found that AP-1 recruitment to the 
cell surface and the interaction of Nef with -COP are 
necessary for CD8 down-modulation and subsequent 
degradation [21]. However, they couldn’t confirm the need 
for AP-2 in CD8 nor CD4 down-modulation by knock-
down of AP-2  while several previous reports convincingly 
showed the opposite by knock-down of AP-2 μ2 [14, 25] 
Although there is some evidence for dysfunctional antiviral 
CD8 T cell responses in HIV infection (for review see 
reference [41]), further research has to be done on whether 
Nef impairs infected CD8+ T cell function. The role of CD8 
molecules in the recognition of antigens in association with 
MHC-I molecules is very important and since CD8 positive 
T cells can become infected in transit through a CD4/CD8 
double positive state, it is possible that Nef-dependent CD8 
down-regulation provides a mechanism to avoid antigen 
recognition and cytotoxic responses to pathogens, therefore 
playing an important role in the subversion of the immune 
system during HIV infection. 
CD80 and CD86 
 CD80 and CD86 are two major co-stimulatory proteins 
of the B7 family, present on antigen presenting cells (APCs) 
such as dendritic cells (DCs) and macrophages and provide a 
co-stimulatory signal necessary for T cell activation and 
survival [42]. Different studies showed CD80 and CD86 
down-regulation from the cell surface in macrophage cell 
lines of human and murine origin as well as in human PBL-
derived macrophages after HIV-1 infection [42-44]. 
However, a recent study from Leonard et al. could not show 
CD80 and CD86 down-regulation in primary APCs derived 
from human peripheral blood mononuclear cells or in human 
monocytic cell lines [21]. The two-pronged mechanism 
involved in the Nef mediated down-regulation of 
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CD80/CD86, described by the group of Chaudry, involves 
both a direct binding of Nef to CD80/CD86 to mark the 
molecules for Rac-mediated endocytosis and the activation 
of the PKC-Src-TIAM-Rac pathway to trigger Rac-mediated 
endocytosis. Both actions are mediated by separate Nef 
domains based on the evidence that a point mutation in Nef 
was still able to activate Src and Rac but unable to bind to 
the cytosolic tail of CD80/CD86 and induce internalization 
[44, 15]. Given the role of these two molecules, it has been 
speculated that Nef’s ability to reduce CD80 and CD86 
surface expression in infected cells can prevent the activation 
of naïve T cells, necessary for an efficient recognition and 
elimination of the target cells. T cell activation assays 
showed unaffected presentation of APC endogenous antigen 
to both MHC-II and MHC-I restricted T cell hybridomas in 
the presence of Nef. This activation study was conducted in 
a time frame in which CD80 and CD86 appeared to be 
already down-regulated from the cell surface but MHC-I 
down-regulation still had to occur and therefore the 
contribution of CD80 and CD86 absence on the cells could 
be measured in a more precise way. The same APCs were 
demonstrated to be extremely poor activators of naïve 
primary CD4+ and CD8+ T cells, consistent with loss of co-
stimulatory function mediated by Nef [15]. The results of 
Chaudry et al. [15, 44] would propose an important role for 
Nef-mediated loss of co-stimulatory signals during HIV 
infection dependent on CD80 and CD86 down-regulation. 
However, on the other hand the evidence gathered in primary 
cells by Leonard et al. [21] questions this hypothesis and 
suggests indeed a role of Nef in the loss of co-stimulatory 
signaling, but not necessarily through modulation of CD80 
and CD86. Further experiments in primary cells are therefore 
needed to validate the role of CD80 and CD86 down-
regulation in this context. 
CD28 
 The CD28 molecule is expressed on T cells and is the 
receptor for two other clusters of differentiation expressed in 
APCs, i.e. CD80 and CD86. It therefore plays a role together 
with these two proteins in efficient co-stimulation for the 
activation of T cells. In 2001 Swigut T. et al. demonstrated that 
Nef down-modulates CD28 from the cell surface via a 
mechanism similar to the one involved in CD4 down-
modulation [16]. This work showed, in the Jurkat T cell line, 
that CD28 is removed from the cell surface by both SIV 
(SIVmac239) and HIV-1 (NA7) alleles via accelerated 
endocytosis, most likely by a mechanism that involves clathrin 
coated pits, with the assistance of AP-2. A recent study adds 
more insight in the mechanism, showing that Nef cooperates 
with AP-1 and -COP to down-modulate CD28 from the cell 
surface [21]. Although interesting, these findings are based on 
SupT1 T cell line transfected with chimeras of various surface 
markers (CD4, CD28, CD8, CD80, CD28, CD1d) consisting 
of the cytoplasmic tail of the receptor and the extracellular part 
of HLA-A2. It would be interesting to validate these findings in 
primary cells that stably and consitutively express the native 
receptor, in order to obtain the most relevant data. 
CD1 
 CD1 molecules are non-polymorphic 2-microglobulin-
associated trans-membrane proteins, structurally related to 
MHC-I. They are capable of restricting T cells to antigens 
but in contrast to MHC-I, specialized in presenting lipid and 
glycolipid antigens [45]. Five genes coding for CD1 
molecules are found in humans, and can be classified into 
two groups according to sequence homology: group I, 
consisting of CD1a, CD1b and CD1c molecules, group II 
consists of CD1d and homologues. Both CD1a and CD1d 
have been shown to be down-regulated by Nef [46, 47]. 
 CD1a is an isoform of CD1 expressed on many 
professional antigen presenting cells such as B cells, 
activated monocytes, immature dentritic cells (iDCs) and 
Langerhans cells [48]. This receptor has been shown to be 
significantly down-modulated in iDCs and in CD1a stably 
transfected JY cells infected with HIV-1. The internalized 
CD1a molecules were found to co-localize with Nef in 
intracellular compartments, suggesting that the endocytosis 
process is Nef-mediated [12]. It is believed that CD1a is 
important in mucosal immunity, as it can bind and efficiently 
present antigens to T cells [49]. 
 CD1d, a non polymorphic MHC class-I molecule, 
presents lipid antigens to Natural Killer T cells (NKT) and 
has been shown to be down-regulated by HIV-1 Nef in 
Jurkat T cells and CD4/CD1d expressing HeLa cells by 
accelerated endocytosis from the cell membrane and 
retention in the trans-Golgi network [46, 47]. It is believed 
that as HIV-1 reduces its visibility to MHC-I restricted T 
cells by down-regulating MHC-I molecules from the surface 
of infected cells, it also reduces its visibility to CD1d 
restricted NKT cells by Nef-induced down-regulation of 
CD1d, both cell-types being critical for controlling the virus 
spread in HIV-1 infection [46]. Furthermore, the down-
regulation of CD1d molecules on the cell surface of infected 
cells could be responsible for the loss of NKT cells-mediated 
immune response and impaired NKT cell activation 
following infection [46]. The loss of CD1a instead, is 
believed to be responsible for the disruption of mucosal 
immune responses. 
MODULATION OF CD3 AND CD28 TO BALANCE 
THE ACTIVITY OF THE INFECTED T CELLS 
 The activation of CD4+ T cells requires two signals in 
order to happen efficiently: the interaction of the TCR-CD3 
complex with the MHC class I complex presenting antigen-
specific peptides and a CD28/B7-mediated co-stimulation. 
Efficient HIV and SIV proliferation in vitro requires 
mitogenic activation or engagement of the T cell receptor 
[50]; however, replication in purified T cells, PBLs or 
PBMCs can be measured in the absence of any exogenous 
stimulation. It is well established that HIV-1/2 and SIV Nef 
promote T cell activation in order to establish efficient 
infection of the target cell. Based on the measurement of IL-
2 synthesis and NFAT and NFkB activity, it has been shown 
that HIV-1 Nef increases T cell activation induced by TCR 
or CD28 engagement [51-54]. Moreover, gene expression 
profiling revealed that Nef triggers a transcriptional program 
in T cells which is almost identical to that of anti-CD3 T cell 
activation [55] which favors HIV-1 replication by up-
regulating transcription factors recruited to the LTR [56]. 
 Induction of T cell activation is beneficial for viral 
infection, yet it can be detrimental for the infected T cell, 
500    Current HIV Research, 2011, Vol. 9, No. 7 Landi et al. 
since repeated stimulation of the TCR results in T cell 
apoptosis (a process called Activation Induced Cell Death; 
AICD). To protect T cells from AICD, primate lentiviruses 
have evolved the ability to down-regulate the TCR, which 
might decrease T cell activation to an optimal level, able to 
favor viral infection without reaching AICD. Nef alleles 
from HIV-2, SIVsm and SIVmac efficiently down-regulate 
cell surface CD3 and show impaired TCR-induced NFAT 
activation, a function which is lacking in HIV-1 and its 
SIVcpz precursor [57, 58]. Although CD3 down-regulation 
by Nef is not fully characterized, a direct interaction between 
SIVmac Nef and CD3 has been demonstrated to be surely 
involved in the process [59, 16]. 
THE ROLE OF SURFACE RECEPTOR DOWN-
MODULATION IN THE PREVENTION OF SUPER-
INFECTION 
 HIV superinfection is deleterious for the viability of the 
infected cell and hence the likelihood for efficient viral 
replication [60, 61]. Avoidance of this phenomenon by the 
virus was in the beginning considered to depend solely on 
the down-modulation of CD4. However, this topic has 
generated a continuous debate over the years and more 
recently the discovery of the down-modulation of HIV co-
receptors has highlighted that also the elimination of other 
molecules from the cell surface may contribute to the 
prevention of superinfection. 
 Nef has been reported to modulate the surface expression 
of CCR5, CCR3, which function as co-receptors especially 
in macrophages, T helper 2 cells and microglial cells, and 
CXCR4, which functions as co-receptor mainly in T cells. A 
study from Michel et al. demonstrates the surface down-
regulation of these co-receptors by FACS analysis in CHO 
cells transfected with NefSF2 [11]. Additionally the study 
proved that also CCR1, CCR4, CCR2, CXCR1, CCR3 and 
CXCR2 are down-modulated when Nef is expressed in the 
cell. The study has also demonstrated that the down-
modulation of these chemokines receptors is a conserved 
function among HIV-1 (SF2, NL4-3, NA7), HIV-2 (NEP) 
and SIV (Mac239) alleles [11] but the actual mechanism by 
which HIV Nef down-regulates the surface expression of the 
viral co-receptors is controversial. SIV Nef is dependent on 
clathrin mediated endocytosis for down-modulation of 
CXCR4 [58], while HIV-1 Nef proteins depend on an intact 
acidic cluster and proline rich motif for CXCR4 
internalization [11, 62]. The differential mechanism used by 
SIV and HIV-1 Nef may account for the differential 
efficiency of CXCR4 down-regulation between both Nef 
species. SIV Nef proteins down-modulate the surface 
expression of CXCR4 very efficiently, while HIV Nef 
proteins have a less pronounced effect on CXCR4 surface 
expression, with HIV-2 Nef proteins being more potent than 
HIV-1 [62]. Receptor mutagenesis demonstrated that the 
cytoplasmic tail of CCR5 and CXCR4, which is critical for 
ligand-mediated endocytosis, was completely dispensable for 
this Nef activity but mutation of the highly conserved DRY 
motif in the second intracellular loop of these chemokine 
receptors abolished the Nef-mediated down-regulation of 
CXCR4 [11]. Depending on the cell type and the virus 
tropism, the presence of CCR5, CCR3 or CXCR4 is 
necessary for the viral entry together with an optimal 
expression of CD4 on the surface of the target cell. The fact 
that upon its entry in the cells the virus efficiently down-
regulates all these receptors present on the cell surface 
suggests that this might happen in order to prevent the entry 
of other viral particles: an accumulation of proviral DNA in 
fact would likely cause toxicity and cell death, a condition 
that is not desirable for the virus to efficiently fulfill its life 
cycle. 
 Similar to other viruses [63], the importance of down-
modulation of the primary receptor by HIV is a controversial 
topic. There are studies that support this theory, for instance 
it has been shown that HIV-1 infected cells, as well as SIV-
Nef expressing cells, are resistant to HIV-2 superinfection. 
However, questions have been raised, mainly due to the 
kinetics of the down-regulation: in T cells, this process starts 
only two days after infection, shortly before cells are 
committed to die. This means that there is only a short time 
span in which CD4 down-modulation would confer 
resistance to superinfection. Juan Lama in his extensive 
review [6] proposes that, due to these kinetic observations, 
even if superinfection occurs, it is unlikely that this event 
would affect the final output of viral production and gives 
arguments concerning viral selection and evolutionary 
reasons that would justify superinfection observed in a part 
of HIV-infected individuals.  
 We think that, although there are good arguments to 
question the exclusive importance of CD4 down-modulation 
in the avoidance of superinfection, the experimental 
evidences available today are not enough to support a theory 
in which superinfection is considered beneficial for the virus 
in terms of evolution and fitness, as hypothesized by Lama 
in his review [6]. The effort that HIV puts in down-
modulating not only the CD4 receptor but also the CCR5, 
CCR3 and CXCR4 co-receptors and the subsequent effects 
on superinfection illustrates that the virus does care to avoid 
it. Michel et al. provide a very good characterization of the 
effect of receptor down-modulation on superinfection [10]. 
In this study, TZM cells expressing wild type Nef or Nef 
mutants defective for CD4 down-modulation were infected 
with HIV-1 R5 YU-2. The cells not expressing Nef were 
productively infected, while the ones containing Nef were 
almost totally protected from infection. Interestingly a Nef 
EDAA mutant, lacking the CD4 down-regulation function, 
was still showing residual protection from superinfection 
because it retained the CCR5 down-modulation activity. 
Indeed, a collaborative effect of the down-modulation of the 
CD4 receptor and CCR5 co-receptor is suggested by the fact 
that also cells expressing a Nef mutant lacking CCR5 down-
modulation are protected from HIV infection, although to a 
smaller extent than cells expressing native Nef [10]. The 
authors of this study propose that the avoidance of 
superinfection, necessary for the effective virus replication, 
coexists with the need for a certain level of superinfection, 
necessary for an optimal recombination, selection and thus 
evolution of the virus. Primate lentiviruses appear to have 
evolved time frames during which permission or avoidance 
of superinfection is regulated by gene expression: only 
immediately after infection, but before HIV gene expression 
starts, superinfection could readily occur to allow generation 
of recombinants. A more recent study has demonstrated that 
Nef synthesized from unintegrated viral DNA is able to 
down-modulate the expression of the HIV co-receptors 
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CXCR4 and CCR5 [64] in addition to CD4, highlighting the 
possibility that soon after infection Nef is produced at 
functionally relevant levels to induce the down-regulation of 
the cell receptor used for viral entry. It can be speculated that 
the purpose of this action is to prevent superinfection from 
the very early stages of infection, but additional 
superinfection experiments, especially on primary cells, are 
needed in order to confirm this hypothesis. 
THE ROLE OF SURFACE RECEPTOR MODULAT-
ION IN VIRAL REPLICATION AND VIRUS SPREAD 
 It is widely known and accepted that Nef can enhance 
viral replication through its CD4 down-modulation function. 
Here we will briefly review the mechanism involved in this 
process and the contribution of the up-regulation of the DC-
SIGN molecule to viral spread.  
 Among the first relevant results showing the effect of 
CD4 down-modulation on viral replication in CD4+ primary 
T cells is a study from Lundquist et al. [65], in which T cells 
were infected with an array of HIV-1 viruses containing 
point mutations to Nef residues previously shown to 
selectively impair each of Nef known activities [65]. 
Interestingly, the six Nef point mutants that exhibited the 
strongest impairment in CD4 down-regulation were also the 
ones inducing most delayed replication. Later on, a study of 
Pham et al. [66] evaluated the infection of various cell lines 
and primary cells expressing truncated CD4 molecules 
resistant to down-modulation: the infection proceeded 
normally and virions were released in normal amounts, 
however the infectivity of progeny virions was reduced of 
around 1000-fold [66]. Further studies of Lundquist et al. 
[67] determined that Nef seems to enhance infectivity and 
replication of HIV-1 by the stabilization of gp120 and gp41 
at the cell surface. Moreover, the conclusions of this study 
led to the hypothesis that the removal of CD4 from the 
membrane would stabilize gp120 into the nascent virions 
while leaving them free of CD4 molecules. This possibility 
was already speculated by Lama et al. [68, 6] but the study 
of Lundquist provides relevant characterization and vali-
dation as it is performed in primary blood T lymphocytes. 
 The type II trans-membrane lectin DC-SIGN is expressed 
at the surface of both immature and mature dendritic cells 
(DCs). The function of this molecule is to mediate the 
transmigration of DCs through the vascular and lymphoid 
endothelium (via the binding with the ICAM-2 ligand) and 
the adhesion of DCs to T cells in the antigen presentation 
process to the TCR (via the ICAM-3 ligand present on the 
surface of T cells). In the context of HIV infection, cells 
expressing DC-SIGN are able to retain attached virions in an 
infectious state for several days and transmit them to T cells 
[69]. A study of Sol-Foulon et al. demonstrated that Nef up-
regulates the levels of DC-SIGN on the surface of DCs by 
inhibiting its endocytosis, and that this stabilization of the 
lectin on the cell membrane dramatically increases the ability 
of DCs to cluster with lymphocytes and transmit the virus 
[18]. In order to determine how this happens, HeLa cells 
expressing Nef were used. Nef expression was shown to 
increase DC-SIGN levels on the cell surface and mutational 
analysis on the viral protein revealed that mutation of the 
dileucine motif in the C-terminus of Nef, also crucial for 
CD4 down-modulation, abolished the effects on DC-SIGN. 
In contrast, the mutation of the polyproline motif, important 
for the interaction with proteins carrying the SH3 domain 
and necessary for MHC-I down-modulation, did not impair 
the ability of Nef to modulate surface levels of DC-SIGN. 
The study also evaluates the functional consequences of the 
up-regulation of DC-SIGN in HIV infected cells. 
Microscopic analysis revealed a dramatic increase in the 
formation of clusters between HIV wild type infected DCs 
and activated primary T cells, while cells infected with Nef 
deleted viruses showed a pattern of clustering much more 
similar to that of non infected cells [18]. 
 These results help to clarify an additional receptor 
modulation function of Nef, which seems to be important for 
the Nef-mediated increase of viral spread and transmission to 
T cells. It can be speculated that the enhanced DC-T cell 
clustering due to DC-SIGN up-regulation might have effects 
on the activation of T cells, thus contributing to the state of 
hyper-activation typical of HIV infection. The validation of 
this hypothesis by experimental evidence would add another 
mechanism to the already complex array of functions 
through which HIV Nef manipulates the immune system for 
the benefit of the virus.  
CONCLUSIONS 
 The modulation of surface receptors by the HIV Nef 
protein creates a synergy necessary for the efficient 
replication, infection and pathogenesis of HIV. 
 Several studies over the years have investigated the 
mechanisms underlying these processes and partially 
characterized the protein-protein interactions involved. The 
efforts made up to date permit to gain insight in many of Nef 
receptor-modulating activities. However further studies in 
primary cells are needed to validate the state of the art of 
knowledge, since often results obtained in different cell lines 
have been shown to be contradictory. A better and 
physiologically relevant comprehension of the modulation 
mechanism of each receptor, crucial for optimal outcome of 
HIV infection, will hopefully lead to the design of new 
therapeutic targets and strategies. 
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Table 1. Cell Surface Molecules Modulated by Nef 
 
Cell Surface Receptor Expression Function Down-Modulation Consequences 
 
 
CD1a 
 
 
Antigen presenting cells 
(dendritic cells, monocytes, Langerhans cells, B 
cells) 
 
  
Presents antigens to T cells 
  
  
Impaired immune response 
  
 
 
CD1d 
 
 
Antigen presenting cells 
(dendritic cells, monocytes, Langerhans cells, B 
cells) 
 
  
Presents antigens to NKT cells 
  
  
Impaired immune response 
  
 
CD3* 
 
 
Thymocytes, T lymphocytes 
  
 
Signal transduction together with 
CD28 and TCR 
  
 
Lowers T cell activation to an optimal 
balance  
between viral replication and cellular 
survival 
 
 
CD4 
 
 
CD4 + T lymphocytes monocytes, dendritic 
cells, NK cells 
  
 
HIV-1, HIV-2, SIV receptor, 
immune response to pathogens,  
binds to MHC-II (T cell activation 
upon antigen recognition) 
 
 
Increased replication, impaired 
superinfection,  
impaired T helper-mediated immune 
response 
 
CD8 
 
 
CD8+ T lymphocytes, NK cells, thymocytes 
 
Immune response to pathogen 
infection 
Binds to MHC-I (T cell activation 
upon antigen recognition) 
 
 
Impaired cytotoxic immune response 
  
 
CD28 
 
 
T lymphocytes, NK cells 
  
 
Binds to CD80 and CD86 to 
provide efficient co-stimulation  
 
Impaired T cell activation 
Impaired immune response 
 
CD80/CD86 
 
 
Antigen presenting cells 
(dendritic cells, monocytes) 
 
Co-stimulatory proteins of the B7 
family. 
Provide signals for T cell activation 
and survival 
 
 
Impaired T cell activation 
Impaired immune response 
 
CCR5 
 
 
T lymphocytes, dendritic cells, NK cells, 
monocytes 
 
 
Chemokine receptor (RANTES, 
CCL3, CCL4) 
Co-receptor for HIV  
 
Impaired superinfection 
  
 
 
CCR3 
 
 
 
Thymocytes, T lymphocytes 
  
 
 
Chemokine receptor (RANTES, 
CCL7, CCL11, CCL26) 
Co-receptor for HIV  
 
 
 
Impaired superinfection 
  
 
CXCR4 
 
 
NK cells, dendritic cells, monocytes 
thymocytes, T lymphocytes 
 
Chemokine receptor 
(CXCL12/SDF-1) 
Co-receptor for HIV  
 
 
Impaired superinfection 
  
 
MHC-I 
 
 
NK cells, dendritic cells, monocytes, B cells,  
thymocytes, T lymphocytes 
 
Triggers cytotoxic immune 
response by presenting antigens to 
CD8+ lymphocytes 
 
 
Impaired cytotoxic immune response 
  
 
MHC-II 
 
 
NK cells, dendritic cells, monocytes 
B cells, thymocytes, T lymphocytes 
 
 
Triggers immune response by 
presenting antigens to  
CD4+ lymphocytes 
 
Impaired T helper cell-mediated immune 
response 
  
 
Cell surface receptor 
 
 
Expression 
 
 
Function 
 
 
Up-modulation consequences 
 
 
DC-SIGN 
 
 
Dendritic cells 
 
 
Trans-migration of DCs through 
vascular endothelium. 
Adhesion of DCs to T-cells during 
antigen presentation 
 
 
Increased adhesion of DCs to T cells  
and virus transmission 
Legend: Table shows, for every cell-surface molecule modulated by Nef discussed in the text, the typical pattern of expression on cells of the immune system, the function in normal 
conditions and the consequences of cell-surface expression alteration. 
* Down-regulated by the Nef protein of HIV-2 and some SIV strains. 
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